TRDA
Entrada Therapeutics, Inc. · Healthcare
COO Nathan J Dowden sold $27K of Entrada Therapeutics, Inc.
Sold$26,845
$15.11Price
1,777Shares
−3%Stake
What TRDA did after the filing
- The stock from Tue, Sep 13 open, $12.29
- +68.6%
- S&P 500, same days
- −3.8%
Measured over 30 trading days, to the Oct 25 close.
Traded Thu, Sep 8. Filed Mon, Sep 12, 4:14 PM ET, after the close. Returns use the Sep 13 open and the Oct 25 close. Not investment advice.